Caprion raises record private placement for Canadian biotechnology firm

Guest Contributor
December 20, 2000

Caprion Pharmaceuticals Inc has made Canadian biotechnology history, attracting the largest private placement to date with a $52.5-million investment by venture capital and institutional investors. The Montreal-based proteomics company has now raised $64 million in capital and will use the funds to conduct research for diagnostic compounds and therapeutics products combining sub-cellular biology and large-scale mass spectrometry.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.